240 related articles for article (PubMed ID: 12766894)
1. Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease.
Klein C; Schalla S; Schnackenburg B; Bornstedt A; Hoffmann V; Fleck E; Nagel E
J Magn Reson Imaging; 2003 Jun; 17(6):656-62. PubMed ID: 12766894
[TBL] [Abstract][Full Text] [Related]
2. Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging.
Bunce NH; Keegan J; Gatehouse PD; Moon JC; Firmin DN; Hoffmann V; Pennell DJ
J Magn Reson Imaging; 2002 Aug; 16(2):217-23. PubMed ID: 12203771
[TBL] [Abstract][Full Text] [Related]
3. Multislice breath-hold spiral magnetic resonance coronary angiography in patients with coronary artery disease: effect of intravascular contrast medium.
Knuesel PR; Nanz D; Wolfensberger U; Saranathan M; Lehning A; Luescher TF; Marincek B; von Schulthess GK; Schwitter J
J Magn Reson Imaging; 2002 Dec; 16(6):660-7. PubMed ID: 12451579
[TBL] [Abstract][Full Text] [Related]
4. Breath-hold 3D MR coronary angiography with a new intravascular contrast agent (feruglose)--first clinical experiences.
Sandstede JJ; Pabst T; Wacker C; Wiesmann F; Hoffmann V; Beer M; Kenn W; Bauer W; Hahn D
Magn Reson Imaging; 2001 Feb; 19(2):201-5. PubMed ID: 11358658
[TBL] [Abstract][Full Text] [Related]
5. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs.
Johansson LO; Nolan MM; Taniuchi M; Fischer SE; Wickline SA; Lorenz CH
J Cardiovasc Magn Reson; 1999; 1(2):139-43. PubMed ID: 11550346
[TBL] [Abstract][Full Text] [Related]
6. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients.
Stillman AE; Wilke N; Li D; Haacke M; McLachlan S
J Comput Assist Tomogr; 1996; 20(1):51-5. PubMed ID: 8576482
[TBL] [Abstract][Full Text] [Related]
7. Whole-heart coronary magnetic resonance angiography with MS-325 (Gadofosveset).
Kelle S; Thouet T; Tangcharoen T; Nassenstein K; Chiribiri A; Paetsch I; Schnackenburg B; Barkhausen J; Fleck E; Nagel E
Med Sci Monit; 2007 Nov; 13(11):CR469-474. PubMed ID: 17968293
[TBL] [Abstract][Full Text] [Related]
8. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
[TBL] [Abstract][Full Text] [Related]
9. Spiral coronary angiography using a blood pool agent.
Ringgaard S; Pedersen M; Rickers J; Johansson LO; Börnert P; Pedersen EM
J Magn Reson Imaging; 2005 Aug; 22(2):213-8. PubMed ID: 16028253
[TBL] [Abstract][Full Text] [Related]
10. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional magnetic resonance coronary angiography using a new blood pool contrast agent: initial experience.
Bedaux WL; Hofman MB; Wielopolski PA; de Cock CC; Hoffmann V; Oudkerk M; de Feyter PJ; van Rossum AC
J Cardiovasc Magn Reson; 2002; 4(2):273-82. PubMed ID: 12074142
[TBL] [Abstract][Full Text] [Related]
12. Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement.
Paetsch I; Huber ME; Bornstedt A; Schnackenburg B; Boesiger P; Stuber M; Fleck E; Cavagna F; Nagel E
J Magn Reson Imaging; 2004 Aug; 20(2):288-93. PubMed ID: 15269955
[TBL] [Abstract][Full Text] [Related]
13. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.
Wagner M; Wagner S; Schnorr J; Schellenberger E; Kivelitz D; Krug L; Dewey M; Laule M; Hamm B; Taupitz M
J Magn Reson Imaging; 2011 Oct; 34(4):816-23. PubMed ID: 21769977
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan).
Bremerich J; Roberts TP; Wendland MF; Wyttenbach R; Arheden H; Reddy GP; Shafaghi N; Higgins CB; Saeed M
J Magn Reson Imaging; 2000 Jun; 11(6):622-8. PubMed ID: 10862061
[TBL] [Abstract][Full Text] [Related]
15. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.
Klein C; Nagel E; Schnackenburg B; Bornstedt A; Schalla S; Hoffmann V; Lehning A; Fleck E
MAGMA; 2000 Nov; 11(1-2):65-7. PubMed ID: 11186991
[No Abstract] [Full Text] [Related]
16. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
17. Coronary arteries at 3.0 T: Contrast-enhanced magnetization-prepared three-dimensional breathhold MR angiography.
Bi X; Li D
J Magn Reson Imaging; 2005 Feb; 21(2):133-9. PubMed ID: 15666400
[TBL] [Abstract][Full Text] [Related]
18. Deep venous thrombosis and consecutive pulmonary embolism as the first sign of an ovarian cancer: MR angiography using an intravascular contrast agent (CLARISCAN).
Sandstede JJ; Krause U; Pabst T; Hoffmann V; Braun H; Kenn W; Hahn D
J Magn Reson Imaging; 2000 Sep; 12(3):497-500. PubMed ID: 10992318
[TBL] [Abstract][Full Text] [Related]
19. Breath-hold coronary MR angiography with volume-targeted imaging.
Wielopolski PA; van Geuns RJ; de Feyter PJ; Oudkerk M
Radiology; 1998 Oct; 209(1):209-19. PubMed ID: 9769834
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of non-contrast-enhanced whole-heart magnetic resonance coronary angiography in combination with adenosine stress perfusion cardiac magnetic resonance imaging.
Heer T; Reiter S; Höfling B; Pilz G
Am Heart J; 2013 Dec; 166(6):999-1009. PubMed ID: 24268214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
